Jennison Associates
GBT

Jennison Associates’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Jennison Associates’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-237,172
Closed -$3.94M – 692
2016
Q2 		$3.94M Sell
237,172
-145
-0.1% -$2.92K ﹤0.01% 509
2016
Q1 		$3.76M Sell
237,317
-75,505
-24% -$1.34M ﹤0.01% 502
2015
Q4 		$10.1M Sell
312,822
-56,709
-15% -$2.46M 0.01% 483
2015
Q3 		$15.6M Buy
+369,531
New +$17.4M 0.02% 466

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates's GBT Position: Q3 2016 in Review

Jennison Associates sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2016, closing a stake of 237,172 shares — an estimated $3.94M sold.

Jennison Associates first reported a position in GBT in Q3 2015 and held it in 4 quarters. The position peaked at $15.6M in Q3 2015. 84 funds tracked by Wall St. Rank hold GBT as of Q3 2016.

  • Jennison Associates reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Jennison Associates sold 237,172 Global Blood Therapeutics, Inc. shares in Q3 2016, an estimated $3.94M.
  • Jennison Associates first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 4 quarters.
  • Jennison Associates's Global Blood Therapeutics, Inc. position peaked at $15.6M in Q3 2015.
  • 84 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2016.

Based on Jennison Associates's 13F filing for Q3 2016, filed 1 Nov 2016.